Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for biote Corp. (BTMD : NSDQ)

• Company Description    BioTE Holdings, LLC is a medical practice-building business within the hormone optimization space. BioTE Holdings, LLC, formerly known as Haymaker Acquisition Corp. III, is based in NEW YORK. Number of Employees: 217

• Price / Volume Information    Yesterday's Closing Price: $2.60 Daily Weekly Monthly 20 Day Moving Average: 116,920 shares Shares Outstanding: 45.66 (millions) Market Capitalization: $118.72 (millions) Beta: 1.16 52 Week High: $6.30 52 Week Low: $2.32 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.17% 1.34% 12 Week -9.09% -10.56% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1875 W. WALNUT HILL LN SUITE 100 - IRVING,TX 75038 USA ph: 844-604-1246 fax: 888-496-0394 ir@biote.com https://biote.com

• General Corporate Information    Officers Bret Christensen - Chief Executive Officer and Director Marc D. Beer - Executive Chairman and Director Robert C. Peterson - Chief Financial Officer Dana Jacoby - Director Mark Cone - Director Peer Information biote Corp. (BJCT) biote Corp. (CADMQ) biote Corp. (APNO) biote Corp. (UPDC) biote Corp. (IMTIQ) biote Corp. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 090683103 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/11/26 Share - Related Items Shares Outstanding: 45.66 Most Recent Split Date: (:1) Beta: 1.16 Market Capitalization: $118.72 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.05 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.31 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/11/26

• Fundamental Ratios P/E Current FY Estimate: 8.39 Trailing 12 Months: 5.20 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 3.39 Price / Sales: 0.61 EPS Growth vs. Year Ago Period: -33.33% vs. Previous Quarter: 120.00% Sales Growth vs. Year Ago Period: -6.67% vs. Previous Quarter: -1.86% ROE 12/31/25 - - 09/30/25 - -21.86 06/30/25 - -21.00 ROA 12/31/25 - - 09/30/25 - 15.68 06/30/25 - 18.26 Current Ratio 12/31/25 - - 09/30/25 - 1.01 06/30/25 - 0.98 Quick Ratio 12/31/25 - - 09/30/25 - 0.72 06/30/25 - 0.74 Operating Margin 12/31/25 - - 09/30/25 - 9.25 06/30/25 - 10.36 Net Margin 12/31/25 - - 09/30/25 - 14.72 06/30/25 - 15.73 Pre-Tax Margin 12/31/25 - - 09/30/25 - 15.72 06/30/25 - 19.17 Book Value 12/31/25 - - 09/30/25 - -1.82 06/30/25 - -2.14 Inventory Turnover 12/31/25 - - 09/30/25 - 3.80 06/30/25 - 3.94 Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - -

Powered by Zacks Investment Research ©